ADAPTIN BIO, INC.
Company Information
Industry
Biological Products, (No Diagnostic Substances)
SIC Code
2836
Entity Type
operating
SEC Category
Non-accelerated filerSmaller reporting companyEmerging growth company
State of Incorporation
DE
Business Address
3540 TORINGDON WAY, CHARLOTTE, NC, 28277
Mailing Address
3540 TORINGDON WAY, CHARLOTTE, NC, 28277
Phone
(888) 609-1498
Fiscal Year End
1231
EIN
881566415
Financial Overview
FY2025
-$3.12M
Net Income
$4.34M
Total Liabilities
-$978K
Stockholders' Equity
$-0.66
EPS
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 10-K Annual financial report | April 1, 2026 | View on SEC |
| 8-K Current report of material events | December 23, 2025 | View on SEC |
| 10-Q Quarterly financial report | November 14, 2025 | View on SEC |
| 8-K Current report of material events | October 6, 2025 | View on SEC |
| 4 Insider stock transaction report | September 10, 2025 | View on SEC |
| 4 Insider stock transaction report | September 10, 2025 | View on SEC |
| 4 Insider stock transaction report | September 10, 2025 | View on SEC |
| 4 Insider stock transaction report | September 10, 2025 | View on SEC |
| 4 Insider stock transaction report | September 10, 2025 | View on SEC |
| 4 Insider stock transaction report | September 10, 2025 | View on SEC |
Annual Reports
10-K
April 1, 2026
- FDA clearance granted for Phase 1/2a multi-dose clinical trials for lead drug APTN-101.
- Proprietary 'hitchhiking' platform successfully bypasses the blood-brain barrier to treat glioblastoma.
Related Companies
Companies in the same industry (SIC: 2836)
Adaptive Biotechnologies Corp
ADPT
Biological Products, (No Diagnostic Substances)
Voyager Therapeutics, Inc.
VYGR
Biological Products, (No Diagnostic Substances)
Immunovant, Inc.
IMVT
Biological Products, (No Diagnostic Substances)
Cardiff Oncology, Inc.
CRDF
Biological Products, (No Diagnostic Substances)
Kodiak Sciences Inc.
KOD
Biological Products, (No Diagnostic Substances)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.